Diagnostic product maker Gen-Probe Inc (GPRO) has made a $50 million strategic investment in privately-held DNA sequencing firm Pacific Biosciences Inc (PacBio). The companies will collaborate on developing products based on their proprietary technologies. Per the deal, the companies will combine their efforts to develop new clinical diagnostic systems, leveraging PacBio’s Single Molecule Real Time (SMRT) [...] (GPRO) Gen-Probe Invests $50 Million in Pacific Biosciences